AG
ETNB

Algert Global’s 89bio ETNB Stock Holding History

Algert Global’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-121,981
Closed -$1.2M – 1187
2025
Q2 		$1.2M Sell
121,981
-65,010
-35% -$538K 0.03% 766
2025
Q1 		$1.36M Buy
186,991
+1,584
+0.9% +$13.8K 0.03% 712
2024
Q4 		$1.45M Buy
185,407
+123,190
+198% +$1.01M 0.03% 706
2024
Q3 		$460K Buy
62,217
+31,630
+103% +$266K 0.01% 915
2024
Q2 		$245K Buy
30,587
+7,203
+31% +$64.3K 0.01% 1205
2024
Q1 		$272K Sell
23,384
-23,440
-50% -$259K 0.01% 907
2023
Q4 		$523K Hold
46,824
– – 0.02% 813
2023
Q3 		$723K Sell
46,824
-105,005
-69% -$1.76M 0.03% 636
2023
Q2 		$2.88M Buy
151,829
+114,864
+311% +$2.02M 0.13% 260
2023
Q1 		$563K Buy
+36,965
New +$482K 0.03% 793

Other funds holding ETNB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Algert Global's ETNB Position: Q3 2025 in Review

Algert Global sold out of 89bio (ETNB) in Q3 2025, closing a stake of 121,981 shares — an estimated $1.2M sold.

Algert Global first reported a position in ETNB in Q1 2023 and held it in 10 quarters. The position peaked at $2.88M in Q2 2023. 198 funds tracked by Wall St. Rank hold ETNB as of Q3 2025.

  • Algert Global reported no remaining 89bio position as of Q3 2025 after selling out during the quarter.
  • Algert Global sold 121,981 89bio shares in Q3 2025, an estimated $1.2M.
  • Algert Global first reported a position in 89bio in Q1 2023 and held it in 10 quarters.
  • Algert Global's 89bio position peaked at $2.88M in Q2 2023.
  • 198 funds tracked by Wall St. Rank held 89bio as of Q3 2025.

Based on Algert Global's 13F filing for Q3 2025, filed 14 Nov 2025.